25.0%); there was a greater proportion of patients treated with eluxadoline 75 mg who were responders compared with the placebo group among this subgroup, although this did not reach statistical significance.
1
—
—
25.0%); there was a greater proportion of patients treated with eluxadoline 75 mg who were responders compared with the placebo group among this subgroup, although this did not reach statistical significance.